Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-25 | New | $763,000,000 | $763,000,000 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Jack Boyle | Executive |
| Andrew Gonce | Executive |
| Kass Harrold | Executive |
| Michael Heffernan | Director |
| Jake Longenecker | Executive |
| Matthew Maletta | Executive |
| Mick Mc Guinness | Executive |
| Joshua Murray | Director |
| Teresa Sanzottera | Executive |
| Scott Sims | Executive |
| Matthew Stober | Director |
| Stephen Welch | Director, Executive |
| Jeffrey Wiegers | Executive |
| Jonathan Zinman | Director |